StartsideMEHCQ • OTCMKTS
add
23andMe Holding Co
Forrige sluttkurs
4,24 $
Dagsintervall
4,05 $ - 4,39 $
Årsintervall
0,47 $ - 10,81 $
Markedsverdi
117,60 mill. USD
Gjennomsnittlig volum
575,71k
P/E-tall
-
Utbytte
-
Hovedbørs
OTCMKTS
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(USD) | mars 2025info | Endring år til år |
---|---|---|
Omsetning | 45,15 mill. | −29,49 % |
Driftskostnader | 65,51 mill. | −34,62 % |
Nettoomsetning | −99,35 mill. | 52,43 % |
Netto resultatmargin | −220,04 | 32,54 % |
Fortjeneste per aksje | — | — |
EBITDA | −45,06 mill. | 35,08 % |
Faktisk avgiftssats | 0,00 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
(USD) | mars 2025info | Endring år til år |
---|---|---|
Kontant / kortsiktige inv. | 38,25 mill. | −82,33 % |
Totale aktiva | 159,89 mill. | −59,54 % |
Totale passiva | 186,64 mill. | −9,68 % |
Total egenkapital | −26,74 mill. | — |
Utestående aksjer | 27,54 mill. | — |
P/B-forhold | −4,37 | — |
Avkastning på aktiva | −54,88 % | — |
Avkastning på kapital | −230,70 % | — |
Kontantstrøm
Netto kontantstrøm
(USD) | mars 2025info | Endring år til år |
---|---|---|
Nettoomsetning | −99,35 mill. | 52,43 % |
Kontantstrøm fra drift | −40,73 mill. | −57,97 % |
Kontanter fra investering | −734,00k | 65,80 % |
Kontanter fra finansiering | −529,00k | −126,45 % |
Netto kontantstrøm | −41,99 mill. | −61,95 % |
Fri kontantstrøm | −82,91 mill. | −285,64 % |
Om
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Grunnlagt
apr. 2006
Hovedkvarter
Nettsted
Ansatte
261